The Innovations Symposium brings together forward-thinking researchers, clinicians, and industry professionals who are working to solve Inflammatory Bowel Disease (IBD). Hear a range of perspectives from leaders working within and outside of the IBD field.
Registration is open!
Greg Barton, PhD
Professor, University of California, BerkeleySpeaker Highlights Dr. Barton investigates how the immune system functions to shed light on the mechanisms underlying autoimmunity and inflammatory diseases. Learn more.
Andreas Bäumler, PhD
Professor, University of California, DavisSpeaker Highlights Dr. Bäumler has a long history of pioneering new models and approaches to address key questions about the pathogenesis of gastroenteritis. He is one of the leaders in the field of Salmonella research. Learn more.
Ilana Brito, PhD
Associate Professor, Cornell UniversitySpeaker Highlights Prof. Brito’s lab studies systems-level methods to examine the human microbiome, protein-mediated interactions with human tissue, and horizontal gene transfer, and the transmission of commensal microbes between people and their environments and the health impacts of such transmission events. Learn more.
Jean-Frederic Colombel, MD
Professor, Icahn School of Medicine at Mt. SinaiSpeaker Highlights Dr. Colombel is a clinician and research whose work focuses on advancing the understanding of Inflammatory Bowel Disease and developing effective treatments, to implement major clinical trials that have the potential to significantly improve treatments for patients across the spectrum of the disease. Learn more.
Michael Fischbach, PhD
Professor, Stanford UniversitySpeaker Highlights Dr. Fischbach uses a combination of genomics and chemistry to identify and characterize small molecules from microbes, with an emphasis on the human microbiome. Learn more.
Andrew Goodman, PhD
CNH Long Professor and Chair, Department of Microbial Pathogenesis; Director, Microbial Sciences Institute, Yale UniversitySpeaker Highlights Dr. Goodman seeks to dissect the mechanisms that commensal gut microbes use to compete, cooperate, and antagonize each other in the gut and how microbiome variation impacts our response to external perturbations. Learn more.
Karen Guillemin, PhD
Philip H. Knight Chair and Professor of Biology, University of OregonSpeaker Highlights Dr. Guillemin’s lab strives to understand how hosts and their associated microbial communities shape each other during development and in the context of disease. Learn more.
Iliyan Iliev, PhD
Associate Professor, Weill Cornell MedicineSpeaker Highlights The Iliev laboratory applies translational, experimental and computational approaches to study the role of immunity to mycobiota early and later in life, upon therapeutic interventions and during conditions, such as inflammatory bowel disease, cancer, and immunodeficiencies, where fungi contribute to pathologies. Learn more.
Kate Jeffrey, PhD
Vice President of Immune Therapeutics, ModernaSpeaker Highlights Moderna Immune Therapeutics within Research and Early Development focuses on the discovery and development of therapeutic and prophylactic approaches to autoimmunity, inflammation. Kate’s research has focused on innate immunity and understanding how epigenetics and environmental cues such as the virome contribute to complex immune diseases such as inflammatory bowel disease and hematology using Moderna’s proprietary mRNA technology. Learn more.
Charlie Lees, PhD
Professor, University of Edinburgh; Consultant Gastroenterologist, Western General HospitalSpeaker Highlights Dr. Lees major research activities are at the translational interface between basic science and direct clinical application, and include the genetics and pharmacogenetics of IBD, the role of diet, nutrition, and the gut microbiota in disease aetiopathogenesis and prognosis, IBD therapeutics, monitoring and e-health. Learn more.
Gwendalyn Randolph, PhD
Professor, Washington University in St. LouisSpeaker Highlights Dr. Randolph is a leading expert in macrophages and lymphatic vasculature. Her lab considers the impact of how transit of cells and molecules out of tissues influences the inflammatory microenvironment. Learn more.
Peter Turnbaugh, PhD
Professor, University of California, San FranciscoSpeaker Highlights Dr. Turnbaugh’s research has focused on the metabolic activities performed by the trillions of microbes that colonize our adult bodies. Dr. Turnbaugh and his research group use interdisciplinary approaches in preclinical models and human cohorts to study the mechanisms through which the gut microbiome influences nutrition and pharmacology. Learn more.